Slingshot Biosciences
United States · $39.3M raised
- Business Model
- B2B
- Website
- slingshotbio.com
- Total Funding
- $39.3M
- Last Round
- $11.0M Series AFeb 2023
- Rounds
- 3
About
Synthetic cell-mimic controls for flow cytometry enabling reproducible, precision research results.
Summary
Slingshot Biosciences is a Biotech company based in United States. It has raised $39.3M in total across 3 rounds, most recently a $11.0M Series A round in Feb 2023. Investors include ARCH Venture Partners, Northpond Ventures and Anterra Capital.
Tech & App Stack
10 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Feb 2023
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...